Capsid-specific T-cell Responses to Natural Infections With Adeno-associated Viruses in Humans Differ From Those of Nonhuman Primates

Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8+ T cells that become reactivated upon gen...

Full description

Saved in:
Bibliographic Details
Published inMolecular therapy Vol. 19; no. 11; pp. 2021 - 2030
Main Authors Li, Hua, Lasaro, Marcio O, Jia, Bei, Lin, Shih Wen, Haut, Larissa H, High, Katherine A, Ertl, Hildegund CJ
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2011
Elsevier Limited
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8+ T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8+ and CD4+ T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species.
AbstractList Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8 + T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8 + and CD4+ T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species.
Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8 + T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8 + and CD4 + T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species.
Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8(+) T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8(+) and CD4(+) T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species.Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8(+) T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8(+) and CD4(+) T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species.
Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8 super(+) T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8 super(+) and CD4 super(+) T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species.
Author Lasaro, Marcio O
Li, Hua
Jia, Bei
Ertl, Hildegund CJ
High, Katherine A
Haut, Larissa H
Lin, Shih Wen
Author_xml – sequence: 1
  givenname: Hua
  surname: Li
  fullname: Li, Hua
  organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA
– sequence: 2
  givenname: Marcio O
  surname: Lasaro
  fullname: Lasaro, Marcio O
  organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA
– sequence: 3
  givenname: Bei
  surname: Jia
  fullname: Jia, Bei
  organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA
– sequence: 4
  givenname: Shih Wen
  surname: Lin
  fullname: Lin, Shih Wen
  organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA
– sequence: 5
  givenname: Larissa H
  surname: Haut
  fullname: Haut, Larissa H
  organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA
– sequence: 6
  givenname: Katherine A
  surname: High
  fullname: High, Katherine A
  organization: Department of Pediatrics, the Children's Hospital of Philadelphia and Howard Hughes Medical Institute, Philadelphia, Pennsylvania, USA
– sequence: 7
  givenname: Hildegund CJ
  surname: Ertl
  fullname: Ertl, Hildegund CJ
  email: ertl@wistar.upenn.edu
  organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21587208$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1rFDEUhgep2A-98QdIwAtFmDUfk5nMjVBWawuliqx6GbLJiZuyk4xJpuAP8H-bYdvSluJVDjnP-3K-Dqs9HzxU1UuCFwQz8X7IC4oJWQjypDognPIaY9rs3cak3a8OU7osEeF9-6zap4SLjmJxUP1dqjE5U6cRtLNOo1WtYbtF3yCNwSdIKAd0ofIU1RadeQs6u_KPfrq8QccGfKhVSkE7lcGgHy5Os8Z5dDoNqnAfnbUQ0UkMA1ptQgIULLoIfjOn0dfohiJMz6unVm0TvLh-j6rvJ59Wy9P6_Mvns-Xxea0bwXLNDRbtGq9x1xGKraGNAmVZY5iyvG1Mh_teaUv0mneK6U5z1hveWQKWKSZadlR92PmO03oAo8Hn0pcc5zLiHxmUk_cz3m3kr3AlGaWUN7gYvLk2iOH3BCnLwaV5YMpDmJLsMWUMt5gV8u1_SdK2grYC09n09QP0MkzRl0FI0vWkF7hvaKFe3a39tuibXRYA7wAdQ0oRrNQuq3ldpRW3lQTL-VzkkOV8LlKQInn3QHLj-ijc7GAoG7pyEGXSDrwG42I5C2mCe0z2D3MP0zc
CitedBy_id crossref_primary_10_1016_j_omtm_2025_101441
crossref_primary_10_1002_jimd_12637
crossref_primary_10_1038_mt_2013_176
crossref_primary_10_1172_JCI66611
crossref_primary_10_1128_JVI_00209_12
crossref_primary_10_1016_j_ymthe_2020_01_004
crossref_primary_10_3390_jcm9020589
crossref_primary_10_1371_journal_pone_0067748
crossref_primary_10_1111_hae_14023
crossref_primary_10_1177_01926233231201408
crossref_primary_10_1016_j_ymthe_2017_04_003
crossref_primary_10_1089_hum_2016_172
crossref_primary_10_1016_j_pharmthera_2019_107453
crossref_primary_10_1002_rmv_1762
crossref_primary_10_1089_crispr_2020_0025
crossref_primary_10_1038_mtm_2014_33
crossref_primary_10_1016_j_preteyeres_2020_100915
crossref_primary_10_3389_fimmu_2020_00670
crossref_primary_10_4049_jimmunol_1200620
crossref_primary_10_1016_j_omtm_2022_01_005
crossref_primary_10_1182_blood_2012_10_460733
crossref_primary_10_1016_j_omtn_2024_102280
crossref_primary_10_1038_mt_2012_153
crossref_primary_10_1016_j_omtm_2022_07_018
crossref_primary_10_1089_hgtb_2018_038
crossref_primary_10_1016_j_coviro_2016_06_001
crossref_primary_10_1089_hum_2023_119
crossref_primary_10_1016_j_omtm_2021_03_016
crossref_primary_10_1089_hum_2012_246
crossref_primary_10_1007_s40259_017_0255_0
crossref_primary_10_1089_hum_2014_050
crossref_primary_10_1186_1744_8069_10_54
crossref_primary_10_3389_fimmu_2021_666666
crossref_primary_10_1038_gt_2012_98
crossref_primary_10_1172_JCI122372
crossref_primary_10_1007_s40259_023_00585_7
crossref_primary_10_1182_blood_2013_01_306647
crossref_primary_10_1186_s11689_018_9234_0
crossref_primary_10_1016_j_omtm_2019_05_014
crossref_primary_10_1016_j_ymthe_2019_11_014
crossref_primary_10_1089_hum_2021_258
crossref_primary_10_1089_hum_2017_150
crossref_primary_10_1016_j_omtm_2019_12_008
crossref_primary_10_1016_j_ymthe_2019_12_010
crossref_primary_10_1055_a_1757_9810
crossref_primary_10_1146_annurev_virology_101416_041936
crossref_primary_10_3389_fimmu_2022_975803
crossref_primary_10_1016_j_omtm_2017_04_004
crossref_primary_10_1038_s41575_022_00729_0
crossref_primary_10_1089_hum_2023_225
crossref_primary_10_1089_hum_2020_113
crossref_primary_10_4049_jimmunol_1202905
crossref_primary_10_3389_fimmu_2021_753467
crossref_primary_10_3389_fimmu_2019_03110
crossref_primary_10_1208_s12248_021_00678_7
crossref_primary_10_1517_21678707_2015_1088780
crossref_primary_10_1096_fj_201801391R
crossref_primary_10_1016_j_cellimm_2017_11_006
crossref_primary_10_1007_s10238_024_01541_7
crossref_primary_10_1016_j_ymthe_2023_07_020
crossref_primary_10_3390_biomedicines9060613
crossref_primary_10_1038_mt_2011_218
crossref_primary_10_23736_S2724_6302_21_02381_1
Cites_doi 10.1038/sj.mt.6300090
10.1038/nm1371
10.1182/blood.V116.21.248.248
10.1073/pnas.94.11.5804
10.1038/mt.2008.87
10.1016/j.ymthe.2004.12.022
10.1038/nm1549
10.1073/pnas.92.16.7257
10.1038/mt.2010.267
10.1128/JVI.78.12.6381-6388.2004
10.1093/oxfordjournals.aje.a120913
10.1038/nm1358
10.1038/sj.gt.3300548
10.1128/JVI.02021-06
10.1073/pnas.0904514106
10.1371/journal.ppat.1000503
10.1089/hum.2007.001
10.1128/JVI.02497-06
10.1182/blood-2003-05-1446
10.4049/jimmunol.0900317
10.1182/blood-2004-07-2908
10.1016/j.ymthe.2005.09.009
10.1016/0092-8674(83)90342-2
10.1038/nature05115
10.1038/ng0797-270
10.1128/JVI.77.8.4911-4927.2003
10.1182/blood-2008-07-167510
10.1093/oxfordjournals.aje.a112394
10.1182/blood-2006-03-010181
10.1007/978-1-59745-170-3_28
10.1073/pnas.0937739100
10.1086/587993
10.1128/JVI.78.14.7392-7399.2004
ContentType Journal Article
Copyright 2011 The American Society of Gene & Cell Therapy
Copyright Nature Publishing Group Nov 2011
Copyright © 2011 The American Society of Gene & Cell Therapy 2011 The American Society of Gene & Cell Therapy
Copyright_xml – notice: 2011 The American Society of Gene & Cell Therapy
– notice: Copyright Nature Publishing Group Nov 2011
– notice: Copyright © 2011 The American Society of Gene & Cell Therapy 2011 The American Society of Gene & Cell Therapy
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7QO
7T5
7U9
8FD
FR3
H94
P64
7X8
5PM
DOI 10.1038/mt.2011.81
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Proquest Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Biotechnology Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Virology and AIDS Abstracts
Biotechnology Research Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
MEDLINE


MEDLINE - Academic
Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
DocumentTitleAlternate T Cell Responses to AAV Capsid
EISSN 1525-0024
EndPage 2030
ExternalDocumentID PMC3222540
4069954371
21587208
10_1038_mt_2011_81
S152500161632799X
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States--US
Texas
Pennsylvania
GeographicLocations_xml – name: Texas
– name: Pennsylvania
– name: United States--US
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: P01HL078810
– fundername: NCI NIH HHS
  grantid: P30 CA010815
– fundername: NHLBI NIH HHS
  grantid: P01 HL078810
– fundername: Howard Hughes Medical Institute
– fundername: NCI NIH HHS
  grantid: CA10815
GroupedDBID ---
--K
0R~
123
1B1
29M
2WC
36B
39C
3V.
4.4
53G
6I.
7X7
88E
8FE
8FH
8FI
8FJ
AACTN
AAEDW
AAFTH
AAIAV
AALRI
AAVLU
AAXUO
ABAWZ
ABJNI
ABMAC
ABUDA
ABUWG
ABVKL
ACGFO
ACGFS
ACPRK
ADBBV
ADFRT
ADJPV
ADMUD
ADQMX
AEDAW
AENEX
AFKRA
AFTJW
AGAYW
AHMBA
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DU5
E3Z
EBS
EJD
EMB
EMOBN
F5P
FDB
FEDTE
FRP
FYUFA
GX1
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IHE
JIG
JSO
KQ8
LG5
LK8
M1P
M41
M7P
NCXOZ
NQ-
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
RCE
RIG
RNS
RNTTT
ROL
RPM
RPZ
SEW
SSZ
SV3
TR2
UHS
UKHRP
W2D
XPP
ZA5
ZMT
AAMRU
AAYWO
AAYXX
ABDGV
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
AEUPX
AFPUW
AGCQF
AIGII
AKAPO
AKBMS
AKRWK
AKYEP
ALIPV
APXCP
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AZQEC
DWQXO
EFKBS
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7QO
7T5
7U9
8FD
FR3
H94
P64
7X8
5PM
ID FETCH-LOGICAL-c483t-5d086b0b077120fd24aeaf34d3af564d7099acf1cb57a3c7c539d57f1ef3a3863
IEDL.DBID 7X7
ISSN 1525-0016
1525-0024
IngestDate Thu Aug 21 14:08:32 EDT 2025
Fri Jul 11 06:37:17 EDT 2025
Mon Jul 21 09:42:18 EDT 2025
Fri Jul 25 11:08:23 EDT 2025
Thu Apr 03 07:04:01 EDT 2025
Thu Apr 24 23:03:10 EDT 2025
Tue Jul 01 01:46:39 EDT 2025
Fri Feb 23 02:27:14 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c483t-5d086b0b077120fd24aeaf34d3af564d7099acf1cb57a3c7c539d57f1ef3a3863
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://dx.doi.org/10.1038/mt.2011.81
PMID 21587208
PQID 1791980942
PQPubID 2042164
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3222540
proquest_miscellaneous_902330603
proquest_miscellaneous_1668268020
proquest_journals_1791980942
pubmed_primary_21587208
crossref_citationtrail_10_1038_mt_2011_81
crossref_primary_10_1038_mt_2011_81
elsevier_sciencedirect_doi_10_1038_mt_2011_81
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-11-01
PublicationDateYYYYMMDD 2011-11-01
PublicationDate_xml – month: 11
  year: 2011
  text: 2011-11-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Milwaukee
PublicationTitle Molecular therapy
PublicationTitleAlternate Mol Ther
PublicationYear 2011
Publisher Elsevier Inc
Elsevier Limited
Nature Publishing Group
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
– name: Nature Publishing Group
References Gao, Alvira, Somanathan, Lu, Vandenberghe, Rux (bib13) 2003; 100
Nathwani, Tuddenham, Rosales, McIntosh, Riddell, Rustagi (bib30) 2010; 116
Nathwani, Gray, McIntosh, Ng, Zhou, Spence (bib9) 2007; 109
Radziewicz, Ibegbu, Fernandez, Workowski, Obideen, Wehbi (bib27) 2007; 81
Arruda, Stedman, Nichols, Haskins, Nicholson, Herzog (bib6) 2005; 105
Fox, Hall, Cooney (bib24) 1977; 105
McCoy, Tatsis, Korioth-Schmitz, Lasaro, Hensley, Lin (bib32) 2007; 81
Arruda, Schuettrumpf, Herzog, Nichols, Robinson, Lotfi (bib3) 2004; 103
Amara (bib19) 2009; 485
Yang, Xiang, Ertl, Wilson (bib28) 1995; 92
Gao, Vandenberghe, Alvira, Lu, Calcedo, Zhou (bib14) 2004; 78
Roy, Vandenberghe, Kryazhimskiy, Grant, Calcedo, Yuan (bib22) 2009; 5
Li, Murphy, Giles-Davis, Edmonson, Xiang, Li (bib11) 2007; 15
Wang, Figueredo, Calcedo, Lin, Wilson (bib12) 2007; 18
Reyes-Sandoval, Fitzgerald, Grant, Roy, Xiang, Li (bib21) 2004; 78
Toromanoff, Chérel, Guilbaud, Penaud-Budloo, Snyder, Haskins (bib10) 2008; 16
Sabatino, Mingozzi, Hui, Chen, Colosi, Ertl (bib16) 2005; 12
Wherry, Blattman, Murali-Krishna, van der Most, Ahmed (bib25) 2003; 77
Monahan, Samulski, Tazelaar, Xiao, Nichols, Bellinger (bib7) 1998; 5
Fox, Brandt, Wassermann, Hall, Spigland, Kogon (bib23) 1969; 89
Tatsis, Lasaro, Lin, Haut, Xiang, Zhou (bib31) 2009; 182
Mingozzi, Meulenberg, Hui, Basner-Tschakarjan, Hasbrouck, Edmonson (bib18) 2009; 114
Priddy, Brown, Kublin, Monahan, Wright, Lalezari, Merck V520-016 Study Group (bib33) 2008; 46
Samulski, Srivastava, Berns, Muzyczka (bib15) 1983; 33
Li, Tuyishime, Wu, Giles-Davis, Zhou, Xiao (bib29) 2011; 19
Manno, Pierce, Arruda, Glader, Ragni, Rasko (bib1) 2006; 12
Snyder, Miao, Patijn, Spratt, Danos, Nagy (bib5) 1997; 16
Mingozzi, Maus, Hui, Sabatino, Murphy, Rasko (bib2) 2007; 13
Herzog, Hagstrom, Kung, Tai, Wilson, Fisher (bib4) 1997; 94
Chattopadhyay, Price, Harper, Betts, Yu, Gostick (bib20) 2006; 12
Day, Kaufmann, Kiepiela, Brown, Moodley, Reddy (bib26) 2006; 443
Davidoff, Gray, Ng, Zhang, Zhou, Spence (bib8) 2005; 11
Brantly, Chulay, Wang, Mueller, Humphries, Spencer (bib17) 2009; 106
Snyder (10.1038/mt.2011.81_bib5) 1997; 16
Mingozzi (10.1038/mt.2011.81_bib2) 2007; 13
Amara (10.1038/mt.2011.81_bib19) 2009; 485
Wang (10.1038/mt.2011.81_bib12) 2007; 18
Roy (10.1038/mt.2011.81_bib22) 2009; 5
Sabatino (10.1038/mt.2011.81_bib16) 2005; 12
Monahan (10.1038/mt.2011.81_bib7) 1998; 5
Chattopadhyay (10.1038/mt.2011.81_bib20) 2006; 12
Fox (10.1038/mt.2011.81_bib24) 1977; 105
Tatsis (10.1038/mt.2011.81_bib31) 2009; 182
Wherry (10.1038/mt.2011.81_bib25) 2003; 77
Mingozzi (10.1038/mt.2011.81_bib18) 2009; 114
Fox (10.1038/mt.2011.81_bib23) 1969; 89
Gao (10.1038/mt.2011.81_bib13) 2003; 100
Reyes-Sandoval (10.1038/mt.2011.81_bib21) 2004; 78
Nathwani (10.1038/mt.2011.81_bib9) 2007; 109
Priddy (10.1038/mt.2011.81_bib33) 2008; 46
Manno (10.1038/mt.2011.81_bib1) 2006; 12
Davidoff (10.1038/mt.2011.81_bib8) 2005; 11
Arruda (10.1038/mt.2011.81_bib3) 2004; 103
Li (10.1038/mt.2011.81_bib29) 2011; 19
Brantly (10.1038/mt.2011.81_bib17) 2009; 106
Day (10.1038/mt.2011.81_bib26) 2006; 443
Gao (10.1038/mt.2011.81_bib14) 2004; 78
Arruda (10.1038/mt.2011.81_bib6) 2005; 105
Yang (10.1038/mt.2011.81_bib28) 1995; 92
Herzog (10.1038/mt.2011.81_bib4) 1997; 94
Nathwani (10.1038/mt.2011.81_bib30) 2010; 116
Li (10.1038/mt.2011.81_bib11) 2007; 15
McCoy (10.1038/mt.2011.81_bib32) 2007; 81
Radziewicz (10.1038/mt.2011.81_bib27) 2007; 81
Samulski (10.1038/mt.2011.81_bib15) 1983; 33
Toromanoff (10.1038/mt.2011.81_bib10) 2008; 16
References_xml – volume: 19
  start-page: 536
  year: 2011
  end-page: 546
  ident: bib29
  article-title: Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice
  publication-title: Mol Ther
– volume: 11
  start-page: 875
  year: 2005
  end-page: 888
  ident: bib8
  article-title: Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models
  publication-title: Mol Ther
– volume: 12
  start-page: 972
  year: 2006
  end-page: 977
  ident: bib20
  article-title: Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry
  publication-title: Nat Med
– volume: 105
  start-page: 3458
  year: 2005
  end-page: 3464
  ident: bib6
  article-title: Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model
  publication-title: Blood
– volume: 485
  start-page: 417
  year: 2009
  end-page: 424
  ident: bib19
  article-title: Methods for quantitating antigen-specific T cell responses using functional assays in rhesus macaques
  publication-title: Methods Mol Biol
– volume: 114
  start-page: 2077
  year: 2009
  end-page: 2086
  ident: bib18
  article-title: AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
  publication-title: Blood
– volume: 92
  start-page: 7257
  year: 1995
  end-page: 7261
  ident: bib28
  article-title: Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo
  publication-title: Proc Natl Acad Sci USA
– volume: 116
  start-page: 114
  year: 2010
  ident: bib30
  article-title: Early clinical trial results following administration of a low dose of a novel self complementary adeno-associated viral vector encoding human factor ix in two subjects with severe haemophilia B
  publication-title: Blood
– volume: 12
  start-page: 1023
  year: 2005
  end-page: 1033
  ident: bib16
  article-title: Identification of mouse AAV capsid-specific CD8+ T cell epitopes
  publication-title: Mol Ther
– volume: 81
  start-page: 6594
  year: 2007
  end-page: 6604
  ident: bib32
  article-title: Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors
  publication-title: J Virol
– volume: 109
  start-page: 1414
  year: 2007
  end-page: 1421
  ident: bib9
  article-title: Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
  publication-title: Blood
– volume: 89
  start-page: 25
  year: 1969
  end-page: 50
  ident: bib23
  article-title: The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness
  publication-title: Am J Epidemiol
– volume: 33
  start-page: 135
  year: 1983
  end-page: 143
  ident: bib15
  article-title: Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV
  publication-title: Cell
– volume: 5
  start-page: 40
  year: 1998
  end-page: 49
  ident: bib7
  article-title: Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia
  publication-title: Gene Ther
– volume: 443
  start-page: 350
  year: 2006
  end-page: 354
  ident: bib26
  article-title: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
  publication-title: Nature
– volume: 78
  start-page: 6381
  year: 2004
  end-page: 6388
  ident: bib14
  article-title: Clades of adeno-associated viruses are widely disseminated in human tissues
  publication-title: J Virol
– volume: 12
  start-page: 342
  year: 2006
  end-page: 347
  ident: bib1
  article-title: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
  publication-title: Nat Med
– volume: 94
  start-page: 5804
  year: 1997
  end-page: 5809
  ident: bib4
  article-title: Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
  publication-title: Proc Natl Acad Sci USA
– volume: 5
  start-page: e1000503
  year: 2009
  ident: bib22
  article-title: Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates
  publication-title: PLoS Pathog
– volume: 182
  start-page: 6587
  year: 2009
  end-page: 6599
  ident: bib31
  article-title: Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens
  publication-title: J Immunol
– volume: 46
  start-page: 1769
  year: 2008
  end-page: 1781
  ident: bib33
  article-title: Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults
  publication-title: Clin Infect Dis
– volume: 16
  start-page: 1291
  year: 2008
  end-page: 1299
  ident: bib10
  article-title: Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle
  publication-title: Mol Ther
– volume: 100
  start-page: 6081
  year: 2003
  end-page: 6086
  ident: bib13
  article-title: Adeno-associated viruses undergo substantial evolution in primates during natural infections
  publication-title: Proc Natl Acad Sci USA
– volume: 18
  start-page: 185
  year: 2007
  end-page: 194
  ident: bib12
  article-title: Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets
  publication-title: Hum Gene Ther
– volume: 77
  start-page: 4911
  year: 2003
  end-page: 4927
  ident: bib25
  article-title: Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment
  publication-title: J Virol
– volume: 13
  start-page: 419
  year: 2007
  end-page: 422
  ident: bib2
  article-title: CD8(+) T-cell responses to adeno-associated virus capsid in humans
  publication-title: Nat Med
– volume: 78
  start-page: 7392
  year: 2004
  end-page: 7399
  ident: bib21
  article-title: Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes
  publication-title: J Virol
– volume: 16
  start-page: 270
  year: 1997
  end-page: 276
  ident: bib5
  article-title: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
  publication-title: Nat Genet
– volume: 103
  start-page: 85
  year: 2004
  end-page: 92
  ident: bib3
  article-title: Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
  publication-title: Blood
– volume: 106
  start-page: 16363
  year: 2009
  end-page: 16368
  ident: bib17
  article-title: Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
  publication-title: Proc Natl Acad Sci USA
– volume: 105
  start-page: 362
  year: 1977
  end-page: 386
  ident: bib24
  article-title: The Seattle Virus Watch. VII. Observations of adenovirus infections
  publication-title: Am J Epidemiol
– volume: 15
  start-page: 792
  year: 2007
  end-page: 800
  ident: bib11
  article-title: Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes
  publication-title: Mol Ther
– volume: 81
  start-page: 2545
  year: 2007
  end-page: 2553
  ident: bib27
  article-title: Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression
  publication-title: J Virol
– volume: 15
  start-page: 792
  year: 2007
  ident: 10.1038/mt.2011.81_bib11
  article-title: Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes
  publication-title: Mol Ther
  doi: 10.1038/sj.mt.6300090
– volume: 12
  start-page: 972
  year: 2006
  ident: 10.1038/mt.2011.81_bib20
  article-title: Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry
  publication-title: Nat Med
  doi: 10.1038/nm1371
– volume: 116
  start-page: 114
  year: 2010
  ident: 10.1038/mt.2011.81_bib30
  article-title: Early clinical trial results following administration of a low dose of a novel self complementary adeno-associated viral vector encoding human factor ix in two subjects with severe haemophilia B
  publication-title: Blood
  doi: 10.1182/blood.V116.21.248.248
– volume: 94
  start-page: 5804
  year: 1997
  ident: 10.1038/mt.2011.81_bib4
  article-title: Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.94.11.5804
– volume: 16
  start-page: 1291
  year: 2008
  ident: 10.1038/mt.2011.81_bib10
  article-title: Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle
  publication-title: Mol Ther
  doi: 10.1038/mt.2008.87
– volume: 11
  start-page: 875
  year: 2005
  ident: 10.1038/mt.2011.81_bib8
  article-title: Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2004.12.022
– volume: 13
  start-page: 419
  year: 2007
  ident: 10.1038/mt.2011.81_bib2
  article-title: CD8(+) T-cell responses to adeno-associated virus capsid in humans
  publication-title: Nat Med
  doi: 10.1038/nm1549
– volume: 92
  start-page: 7257
  year: 1995
  ident: 10.1038/mt.2011.81_bib28
  article-title: Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.92.16.7257
– volume: 19
  start-page: 536
  year: 2011
  ident: 10.1038/mt.2011.81_bib29
  article-title: Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice
  publication-title: Mol Ther
  doi: 10.1038/mt.2010.267
– volume: 78
  start-page: 6381
  year: 2004
  ident: 10.1038/mt.2011.81_bib14
  article-title: Clades of adeno-associated viruses are widely disseminated in human tissues
  publication-title: J Virol
  doi: 10.1128/JVI.78.12.6381-6388.2004
– volume: 89
  start-page: 25
  year: 1969
  ident: 10.1038/mt.2011.81_bib23
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a120913
– volume: 12
  start-page: 342
  year: 2006
  ident: 10.1038/mt.2011.81_bib1
  article-title: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
  publication-title: Nat Med
  doi: 10.1038/nm1358
– volume: 5
  start-page: 40
  year: 1998
  ident: 10.1038/mt.2011.81_bib7
  article-title: Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia
  publication-title: Gene Ther
  doi: 10.1038/sj.gt.3300548
– volume: 81
  start-page: 2545
  year: 2007
  ident: 10.1038/mt.2011.81_bib27
  article-title: Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression
  publication-title: J Virol
  doi: 10.1128/JVI.02021-06
– volume: 106
  start-page: 16363
  year: 2009
  ident: 10.1038/mt.2011.81_bib17
  article-title: Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0904514106
– volume: 5
  start-page: e1000503
  year: 2009
  ident: 10.1038/mt.2011.81_bib22
  article-title: Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000503
– volume: 18
  start-page: 185
  year: 2007
  ident: 10.1038/mt.2011.81_bib12
  article-title: Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets
  publication-title: Hum Gene Ther
  doi: 10.1089/hum.2007.001
– volume: 81
  start-page: 6594
  year: 2007
  ident: 10.1038/mt.2011.81_bib32
  article-title: Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors
  publication-title: J Virol
  doi: 10.1128/JVI.02497-06
– volume: 103
  start-page: 85
  year: 2004
  ident: 10.1038/mt.2011.81_bib3
  article-title: Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
  publication-title: Blood
  doi: 10.1182/blood-2003-05-1446
– volume: 182
  start-page: 6587
  year: 2009
  ident: 10.1038/mt.2011.81_bib31
  article-title: Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0900317
– volume: 105
  start-page: 3458
  year: 2005
  ident: 10.1038/mt.2011.81_bib6
  article-title: Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model
  publication-title: Blood
  doi: 10.1182/blood-2004-07-2908
– volume: 12
  start-page: 1023
  year: 2005
  ident: 10.1038/mt.2011.81_bib16
  article-title: Identification of mouse AAV capsid-specific CD8+ T cell epitopes
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2005.09.009
– volume: 33
  start-page: 135
  year: 1983
  ident: 10.1038/mt.2011.81_bib15
  article-title: Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV
  publication-title: Cell
  doi: 10.1016/0092-8674(83)90342-2
– volume: 443
  start-page: 350
  year: 2006
  ident: 10.1038/mt.2011.81_bib26
  article-title: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
  publication-title: Nature
  doi: 10.1038/nature05115
– volume: 16
  start-page: 270
  year: 1997
  ident: 10.1038/mt.2011.81_bib5
  article-title: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
  publication-title: Nat Genet
  doi: 10.1038/ng0797-270
– volume: 77
  start-page: 4911
  year: 2003
  ident: 10.1038/mt.2011.81_bib25
  article-title: Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment
  publication-title: J Virol
  doi: 10.1128/JVI.77.8.4911-4927.2003
– volume: 114
  start-page: 2077
  year: 2009
  ident: 10.1038/mt.2011.81_bib18
  article-title: AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
  publication-title: Blood
  doi: 10.1182/blood-2008-07-167510
– volume: 105
  start-page: 362
  year: 1977
  ident: 10.1038/mt.2011.81_bib24
  article-title: The Seattle Virus Watch. VII. Observations of adenovirus infections
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a112394
– volume: 109
  start-page: 1414
  year: 2007
  ident: 10.1038/mt.2011.81_bib9
  article-title: Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
  publication-title: Blood
  doi: 10.1182/blood-2006-03-010181
– volume: 485
  start-page: 417
  year: 2009
  ident: 10.1038/mt.2011.81_bib19
  article-title: Methods for quantitating antigen-specific T cell responses using functional assays in rhesus macaques
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-59745-170-3_28
– volume: 100
  start-page: 6081
  year: 2003
  ident: 10.1038/mt.2011.81_bib13
  article-title: Adeno-associated viruses undergo substantial evolution in primates during natural infections
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0937739100
– volume: 46
  start-page: 1769
  year: 2008
  ident: 10.1038/mt.2011.81_bib33
  article-title: Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults
  publication-title: Clin Infect Dis
  doi: 10.1086/587993
– volume: 78
  start-page: 7392
  year: 2004
  ident: 10.1038/mt.2011.81_bib21
  article-title: Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes
  publication-title: J Virol
  doi: 10.1128/JVI.78.14.7392-7399.2004
SSID ssj0011596
Score 2.300293
Snippet Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2021
SubjectTerms Adeno-associated virus
Adolescent
Adult
Animals
Antigens
Capsid - immunology
Cytokines
Dependovirus - immunology
Hemophilia
Human subjects
Humans
Hypotheses
Immunology
Immunophenotyping
Infections
Lymphocytes
Macaca mulatta
Middle Aged
Original
Parvoviridae Infections - immunology
Primates
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Tumor necrosis factor-TNF
Viruses
Young Adult
Title Capsid-specific T-cell Responses to Natural Infections With Adeno-associated Viruses in Humans Differ From Those of Nonhuman Primates
URI https://dx.doi.org/10.1038/mt.2011.81
https://www.ncbi.nlm.nih.gov/pubmed/21587208
https://www.proquest.com/docview/1791980942
https://www.proquest.com/docview/1668268020
https://www.proquest.com/docview/902330603
https://pubmed.ncbi.nlm.nih.gov/PMC3222540
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagFYgLgvJKKZURXDhYdeI8nBMqbVctqKuq2sLeIie2tSuxyXaTPfAD-N_MON5AoeUYeSxZGT--GY-_j5D3SWI04hDGUxtDgKIMy2OpmZKyMmWsrczxcfL5OD29ij9Pk6lPuLW-rHKzJ7qNWjcV5sgPkEYzlxCMRB-X1wxVo_B21Uto3CfbSF2GJV3ZdAi4AOw4fS6U-GGIbTb0pEIeLLqevlOGdx1I_wLOv-sm_ziIRk_IY48g6WHv8qfknql3yINeU_LHDnl47m_Ln5GfR2oJk43ha0qsCKIThnl6etnXxZqWdg0dK8e8Qc98VVbd0m_zbkYPYUNqmPLeM5p-na_W2GdeU5f5b-mxE1eho1WzoJNZ0xraWDpuaqf7Ry-QxwKA7HNyNTqZHJ0yL7vAqliKjiUawpySlzzLwohbHcXKKCtiLZRN0lhnACpVZcOqTDIlqqxKRK6TzIbGCiVkKl6QrbqpzStCAUzEpay0jCxAAQ7duOFaAQwRIjQhD8iHzb8vKs9JjtIY3wt3Ny5ksegK9FMhw4C8G2yXPRPHrVZs48LCY4geGxRwRNxqv7fxc-FXb1v8nmsBeTs0w7pDJ6naNGuwSVOIzCSg7YDQO2xyAEQQknERkJf9zBlGDkhLZhGXAcluzKnBAGm_b7bU85mj_8a7McDZu_8f-WvyyKW_3bPJPbLVrdbmDeCnrtx3i2SfbH86GV9cwtfx2ZdfNhYePQ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ1Lb9NAEIBHJRWPC4LyqKHAIuDAYVXb68fmgFBpGyW0saoqpb2ZtXetRGrsEDtC_QH8HX4js-sHFFpuPXtsWZ7Z3W88L4C3vq-k5hBqB5mHDopQtO9xSQXnqUo8mfG-Lk4eR8HwxPt85p-twc-2FkanVbZ7otmoZZHqf-Tbuo1mn6Mz4n5cfKN6apSOrrYjNGqzOFAX39FlKz-M9lC_71x3sD_ZHdJmqgBNPc4q6kuk-MRO7DB0XDuTrieUyJgnmcj8wJMhMpNIMydN_FCwNEx91pd-mDkqY4LxgOFzb8G6x9CV6cH6p_3o6LiLWyAcmHom3_Wppqm2ISrj2_OqbhjKneuOwH8R9-9MzT-OvsEDuN8wK9mpjewhrKl8A27XUywvNuDOuInPP4Ifu2KB5k11_abOQSITqiMD5LjOxFUlqQoSCdPrg4yaPLC8JKezakp2cAssqGjsRUnyZbZc6XtmOTGxhpLsmXEuZLAs5mQyLUpFioxERW4mDZIj3TkD0fkxnNyISp5ALy9ytQkE8cVLeCq5myF82HibrWwpEHwYc5RjW_C-_fZx2nRB18M4zmMTjWc8nlex1lPMHQvedLKLuvfHlVK0VWHcUEtNIzEeSlfKb7V6jpv9oox_W7cFr7vLuNK1kkSuihXKBAH6ghz53gJyjUwfEQydQJtZ8LS2nO7Nke146NrcgvCSTXUCutH45Sv5bGoajutoHJL9s_-_-Su4O5yMD-PDUXTwHO6Zn--maHMLetVypV4gvVXJy2bJEPh606v0F_ByWmk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Capsid-specific+T-cell+Responses+to+Natural+Infections+With+Adeno-associated+Viruses+in+Humans+Differ+From+Those+of+Nonhuman+Primates&rft.jtitle=Molecular+therapy&rft.au=Li%2C+Hua&rft.au=Lasaro%2C+Marcio+O&rft.au=Jia%2C+Bei&rft.au=Lin%2C+Shih+Wen&rft.date=2011-11-01&rft.pub=Elsevier+Limited&rft.issn=1525-0016&rft.eissn=1525-0024&rft.volume=19&rft.issue=11&rft.spage=2021&rft_id=info:doi/10.1038%2Fmt.2011.81&rft.externalDocID=4069954371
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-0016&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-0016&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-0016&client=summon